References
- World Health OrganizationAntimicrobial ResistanceGenevaWorld Health Organization2018 Available from: http://www.who.int/newsroom/fact-sheets/detail/antimicrobial-resistanceAccessed September 15, 2018
- World Health OrganizationGlobal Tuberculosis Report 2018GenevaWorld Health Organization2018 Available from: http://www.who.int/tb/publications/global_report/enAccessed December 3, 2018
- ChenLLiNLiuMZhangJZhangHHigh prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of ChinaJ Antimicrob Chemother201166102435243721795258
- LiNLiaoXChenLWangJLiuMZhangHAntibiotic susceptibility patterns of Mycobacterium tuberculosis isolates from Guizhou Province of China against 13 antituberculosis drugsMicrob Drug Resist201521329229625599413
- World Health OrganizationWHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 UpdateGeneva, SwitzerlandWorld Health Organization2016 Available from: http://apps.who.int/medicinedocs/en/d/Js23097en/Accessed September 15, 2018
- ZignolMDaraMDeanASDrug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataDrug Resist Updat201316610811524631052
- ZignolMDeanASFalzonDTwenty years of global surveillance of antituberculosis-drug resistanceN Engl J Med2016375111081108927626523
- LiaoSCaiCHuoFMTrends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centreInt J Tuberc Lung Dis201721999099528826447
- Technical Guidance Group of the Fifth National TB Epidemiological Survey, Office of the Fifth National TB Epidemiological Survey2010 National Tuberculosis Epidemiological Survey in ChinaChin J Anti-tuberculosis201234485508 Chinese
- World Health OrganizationLaboratory Services in Tuberculosis Control. Part III: CultureGenevaWorld Health Organization1998 Available from: http://apps.who.int/iris/bitstream/handle/10665/65942/WHO_TB_98.258_(part3).pdf;jsessionid=64EF54513AD4144A520B24B4E3DFCBA5?sequence=3Accessed December 3, 2018
- Challenge TB, TB Care I, TB CAP and partnersStandard operating procedures for culture DST and molecular resistance testingLaboratory Tools, Guidelines and Manuals Available from: http://www.challengetb.org/library/labAccessed December 3, 2018
- World Health OrganizationGuidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-PLUS. WHO/CDS/TB/2001.288 Available from: http://apps.who.int/iris/bitstream/handle/10665/83807/?sequence=1Available from: December 3, 2018
- YuanXZhangTKawakamiKGenotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in ChinaBMC Infect Dis20131331523849244
- WangDYangCKuangTPrevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective studyJpn J Infect Dis201063536837120859008
- ShahNSRichardsonJMoodleyPIncreasing drug resistance in extensively drug-resistant tuberculosis, South AfricaEmerg Infect Dis201117351051321392446
- HuangYWuQXuSLaboratory-based surveillance of extensively drug-resistant tuberculosis in eastern ChinaMicrob Drug Resist201723223624027754791
- DalalAPawaskarADasMResistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over timePLoS One2015101e011679825606853
- ShamaeiMMarjaniMChitsazEFirst-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran – eight years of surveillanceInt J Infect Dis2009135e236e24019285897
- PatilKBagadeSBondeSSharmaSSaraogiGRecent therapeutic approaches for the management of tuberculosis: challenges and opportunitiesBiomed Pharmacother20189973574529710471
- du PlessisNKotzeLALeukesVWalzlGTranslational potential of therapeutics targeting regulatory myeloid cells in tuberculosisFront Cell Infect Microbiol2018833230298121